You appear to be offline. Some data may be unavailable until your connection is restored.

MRNA

Stock

Moderna Inc

Create price alert
$231.35
-$17.34 (6.97%)
At close: Nov 12, 2026, 4:00 PM

Description

Moderna, Inc. is a biotechnology company that develops messenger RNA (mRNA) medicines, using its platform to design, formulate and manufacture mRNA‑based vaccines and therapeutics that instruct cells to produce target proteins. It operates primarily in the healthcare sector, focusing on infectious‑disease vaccines, oncology, rare‑disease and other therapeutic areas. The firm gained global prominence by rapidly bringing its COVID‑19 vaccine, Spikevax, to market and has since expanded its pipeline to include products such as an RSV vaccine, flu candidates and personalized cancer treatments, positioning it as a leading player in the emerging mRNA therapeutics space.

Price Chart

Market just opened
Intraday data has a 15-minute delay. Chart will appear shortly.
Intraday data unavailable

Never miss a move in MRNA

Set alerts for price targets, percentage moves, trailing stops, market open and close prices, after-hours and pre-market changes, new 52-week highs and lows, and more. Get notified the moment they happen.

Create price alert

Other Healthcare stocks in the S&P 500

View all S&P 500 biotechnology stocks →View all S&P 500 Healthcare stocks →View all S&P 500 stocks →